Novel CNS-directed drug delivery systems in Alzheimer's disease and other neurological disorders

Research output: Contribution to journalReview article

19 Citations (Scopus)

Abstract

Increasing knowledge of the neurochemical aspects of central nervous system function raises the possibility of treating Alzheimer's disease (AD) and other neurological diseases by the appropriate manipulation of neurotransmitters, neuromodulators, neurohormones or neurotrophic factors. Clinical application of this knowledge may, however, be inhibited by long standing problems with drug delivery to the central nervous system (CNS). Novel, CNS-directed, drug delivery systems might be used to overcome many of these problems. The problems encountered in drug delivery to the brain, present experience with the clinical use of some novel drug delivery systems and the advantages and disadvantages of these systems will be discussed.

Original languageEnglish (US)
Pages (from-to)623-629
Number of pages7
JournalNeurobiology of Aging
Volume10
Issue number5
DOIs
StatePublished - Jan 1 1989

Fingerprint

Central Nervous System Agents
Drug Delivery Systems
Nervous System Diseases
Neurotransmitter Agents
Alzheimer Disease
Central Nervous System
Nerve Growth Factors
Pharmaceutical Preparations
Brain

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Aging
  • Clinical Neurology
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

@article{77aee5db995e4b39b441afae37cf1f42,
title = "Novel CNS-directed drug delivery systems in Alzheimer's disease and other neurological disorders",
abstract = "Increasing knowledge of the neurochemical aspects of central nervous system function raises the possibility of treating Alzheimer's disease (AD) and other neurological diseases by the appropriate manipulation of neurotransmitters, neuromodulators, neurohormones or neurotrophic factors. Clinical application of this knowledge may, however, be inhibited by long standing problems with drug delivery to the central nervous system (CNS). Novel, CNS-directed, drug delivery systems might be used to overcome many of these problems. The problems encountered in drug delivery to the brain, present experience with the clinical use of some novel drug delivery systems and the advantages and disadvantages of these systems will be discussed.",
author = "Robert Harbaugh",
year = "1989",
month = "1",
day = "1",
doi = "10.1016/0197-4580(89)90155-3",
language = "English (US)",
volume = "10",
pages = "623--629",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "5",

}

Novel CNS-directed drug delivery systems in Alzheimer's disease and other neurological disorders. / Harbaugh, Robert.

In: Neurobiology of Aging, Vol. 10, No. 5, 01.01.1989, p. 623-629.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Novel CNS-directed drug delivery systems in Alzheimer's disease and other neurological disorders

AU - Harbaugh, Robert

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Increasing knowledge of the neurochemical aspects of central nervous system function raises the possibility of treating Alzheimer's disease (AD) and other neurological diseases by the appropriate manipulation of neurotransmitters, neuromodulators, neurohormones or neurotrophic factors. Clinical application of this knowledge may, however, be inhibited by long standing problems with drug delivery to the central nervous system (CNS). Novel, CNS-directed, drug delivery systems might be used to overcome many of these problems. The problems encountered in drug delivery to the brain, present experience with the clinical use of some novel drug delivery systems and the advantages and disadvantages of these systems will be discussed.

AB - Increasing knowledge of the neurochemical aspects of central nervous system function raises the possibility of treating Alzheimer's disease (AD) and other neurological diseases by the appropriate manipulation of neurotransmitters, neuromodulators, neurohormones or neurotrophic factors. Clinical application of this knowledge may, however, be inhibited by long standing problems with drug delivery to the central nervous system (CNS). Novel, CNS-directed, drug delivery systems might be used to overcome many of these problems. The problems encountered in drug delivery to the brain, present experience with the clinical use of some novel drug delivery systems and the advantages and disadvantages of these systems will be discussed.

UR - http://www.scopus.com/inward/record.url?scp=0024343229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024343229&partnerID=8YFLogxK

U2 - 10.1016/0197-4580(89)90155-3

DO - 10.1016/0197-4580(89)90155-3

M3 - Review article

C2 - 2572986

AN - SCOPUS:0024343229

VL - 10

SP - 623

EP - 629

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 5

ER -